USA
The U.S. stock markets posted small gains last week despite mild profit taking. The major stock indices were up four straight weeks, setting a record in the last six months.
At the FOMC meeting last Tuesday, the Fed held interest rates steady but indicated an easing bias. Poor economic data did subsequently prompt some speculative longs to liquidate.
April retail sales and weekly jobless claims came out weaker than expected, so the market is concerned that slow job growth may crimp consumer spending and delay business investment.
Economic sensitive stocks pared gains, but technology stocks led the market rebound on Friday as Intel and Nvidia issued positive guidance.
Since corporate earnings turned out stronger than expected in 1Q/2003, analysts may upgrade estimates for the whole year 2003, which could be further boosted by fiscal stimulus. Moreover, the Fed is also leaning towards easy monetary policies. There has been domestic funds flowing from cash into equities in recent months.
Many investors, now faced with anemic cash deposit yield, have shown renewed interest in equity investment.
Europe
European stocks pared gains last week after having rallied in April. A weakening U.S. dollar triggered some profit taking on concern that a strong Euro exchange rate will make the large European companies less competitive.
Companies such as Aegon, BASF, AXA, Lafarge and Siemens, which all have large operations in the dollar-bloc countries, were under selling pressures. Other companies, such as Pearson, the world's largest textbook publisher and owner of Financial Times, slid on stock rating downgrade. Airline stocks were again under attack.
KLM Royal Dutch Airlines reported large quarterly loss and Air France said that traffic fell in April. Both BOE and ECB also disappointed investors for not cutting interest rates. But, most major European bourses, on a currency-adjusted basis, generate positive returns.
Investors may overweigh the Euroland at the expense of Asia, which would see earnings deterioration in 1H03 because of the deadly virus SARS.
Japan
Japanese stocks climbed again last week after having touched all-time lows in April. NTT DoCoMo and shares of other phone-related companies rose on earnings optimism.
Market also advanced on hopes of government taking measures to buy back more stocks. Tech stocks and exporters rose along with the NASDAQ, but the upward momentum has been somewhat tempered by the poor performance of Sony, which upset investors with a poor 2002-2003 operating result.
The Sony shock' still ripple through the Tech ector and causes investors to look for safe investment alternatives. Investors have therefore shifted funds from risky sectors to less economic-sensitive stocks such as drugs and consumer staples.
Takeda Chemical Industries and Seven-Eleven Japan performed well. anks such as Mizuho Financial Group and Mitsubishi Tokyo Financial also helped push the Topix higher on report that The Bank of Japan may consider buying shares held by the commercial banks to stem the stock market slump.
Is the bear market over for equities?
Brokers are beginning to feel that the worst may be over for global equities. Certainly there have been some encouraging signs in recent weeks.
Wednesday, May 14 - 2003 at 10:03
Peter J. CooperWednesday, May 14 - 2003 at 10:03 UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of AME Info FZ LLC / Emap Limited.
This Article was updated on Saturday, June 09 - 2007
Disclaimer:
The information comprised in this section is not, nor is it held out to be, a solicitation of any person to take any form of investment decision. The content of the AME Info Web site does not constitute advice or a recommendation by AME Info FZ LLC / Emap Limited and should not be relied upon in making (or refraining from making) any decision relating to investments or any other matter. You should consult your own independent financial adviser and obtain professional advice before exercising any investment decisions or choices based on information featured in this AME Info Web site.
AME Info FZ LLC / Emap Limited can not be held liable or responsible in any way for any opinions, suggestions, recommendations or comments made by any of the contributors to the various columns on the AME Info Web site nor do opinions of contributors necessarily reflect those of AME Info FZ LLC / Emap Limited.
In no event shall AME Info FZ LLC / Emap Limited be liable for any damages whatsoever, including, without limitation, direct, special, indirect, consequential, or incidental damages, or damages for lost profits, loss of revenue, or loss of use, arising out of or related to the AME Info Web site or the information contained in it, whether such damages arise in contract, negligence, tort, under statute, in equity, at law or otherwise.
The information comprised in this section is not, nor is it held out to be, a solicitation of any person to take any form of investment decision. The content of the AME Info Web site does not constitute advice or a recommendation by AME Info FZ LLC / Emap Limited and should not be relied upon in making (or refraining from making) any decision relating to investments or any other matter. You should consult your own independent financial adviser and obtain professional advice before exercising any investment decisions or choices based on information featured in this AME Info Web site.
AME Info FZ LLC / Emap Limited can not be held liable or responsible in any way for any opinions, suggestions, recommendations or comments made by any of the contributors to the various columns on the AME Info Web site nor do opinions of contributors necessarily reflect those of AME Info FZ LLC / Emap Limited.
In no event shall AME Info FZ LLC / Emap Limited be liable for any damages whatsoever, including, without limitation, direct, special, indirect, consequential, or incidental damages, or damages for lost profits, loss of revenue, or loss of use, arising out of or related to the AME Info Web site or the information contained in it, whether such damages arise in contract, negligence, tort, under statute, in equity, at law or otherwise.
Browse related articles



Web Feeds